Ironwood Investment Management’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,566
Closed -$40.2K 164
2024
Q4
$40.2K Sell
12,566
-419
-3% -$1.42K 0.02% 166
2024
Q3
$29.1K Buy
12,985
+233
+2% +$538 0.01% 171
2024
Q2
$27.4K Buy
12,752
+63
+0.5% +$112 0.01% 167
2024
Q1
$26K Buy
12,689
+1,006
+9% +$2.01K 0.01% 172
2023
Q4
$26.8K Sell
11,683
-1,118
-9% -$2.43K 0.01% 165
2023
Q3
$21.8K Sell
12,801
-371
-3% -$843 0.01% 164
2023
Q2
$32.5K Sell
13,172
-3,093
-19% -$8.45K 0.02% 165
2023
Q1
$36.6K Buy
16,265
+3,701
+29% +$18.6K 0.02% 160
2022
Q4
$64.2K Sell
12,564
-1,326
-10% -$9.55K 0.04% 160
2022
Q3
$144K Sell
13,890
-12
-0.1% -$143 0.1% 152
2022
Q2
$143K Buy
13,902
+11
+0.1% +$144 0.1% 157
2022
Q1
$246K Buy
13,891
+275
+2% +$5.91K 0.13% 145
2021
Q4
$423K Buy
13,616
+429
+3% +$14.2K 0.21% 128
2021
Q3
$435K Buy
13,187
+32
+0.2% +$946 0.23% 122
2021
Q2
$388K Sell
13,155
-264
-2% -$7.32K 0.2% 134
2021
Q1
$421K Buy
13,419
+1,776
+15% +$59.5K 0.22% 127
2020
Q4
$309K Sell
11,643
-1,962
-14% -$49.6K 0.18% 135
2020
Q3
$365K Buy
+13,605
New +$327K 0.26% 117

Other funds holding CKPT

Ironwood Investment Management's CKPT Position: Q1 2025 in Review

Ironwood Investment Management sold out of Checkpoint Therapeutics (CKPT) in Q1 2025, closing a stake of 12,566 shares — an estimated $40.2K sold.

Ironwood Investment Management first reported a position in CKPT in Q3 2020 and held it in 18 quarters. The position peaked at $435K in Q3 2021. 84 funds tracked by Wall St. Rank hold CKPT as of Q1 2025.

  • Ironwood Investment Management reported no remaining Checkpoint Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Ironwood Investment Management sold 12,566 Checkpoint Therapeutics shares in Q1 2025, an estimated $40.2K.
  • Ironwood Investment Management first reported a position in Checkpoint Therapeutics in Q3 2020 and held it in 18 quarters.
  • Ironwood Investment Management's Checkpoint Therapeutics position peaked at $435K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2025.

Based on Ironwood Investment Management's 13F filing for Q1 2025, filed 15 May 2025.